Scheduled low-dose risperidone for agitation in elderly patients

Annals of Long-Term Care

Volumn 19, Issue 2, 2011, Pages 40-43

  Nguyen, Mathew L ^a   Patel, Shriti B ^b   Shapiro, Michael A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; HALOPERIDOL; LORAZEPAM; RISPERIDONE;

AGED; AGGRESSION; AGITATION; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CREATINE KINASE BLOOD LEVEL; DELIRIUM; DRUG DOSE INCREASE; DRUG EFFICACY; ELECTROCARDIOGRAPHY; FEMALE; HOSPITALIZATION; HUMAN; LOW DRUG DOSE; MALE; MINI MENTAL STATE EXAMINATION; NASOGASTRIC TUBE; NUCLEAR MAGNETIC RESONANCE IMAGING; QT INTERVAL; RESTLESSNESS; SEDATION; SYMPTOM; THROMBOCYTE COUNT; UNSPECIFIED SIDE EFFECT; URINALYSIS;

EID: 79951880162     PISSN: 15247929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Dewing J. Responding agitation in people with dementia. Nurs Older People. 2010;22(6):18-25.
2. Cole MG, McCusker J, Dendukuri N, Han L. Symptoms of delirium among elderly medical inpatients with or without dementia. J Neuropsychiatry Clin Neurosci. 2002;14(2):167-175. (Pubitemid 34556526)
3. Lonergan E, Britton AM, Luxenberg J, Wyller T. Antipsychotics for delirium. Cochrane Database Syst Rev. 2007;18(2):CD005594.
4. De Dyn PP, Katz IR, Brodaty H, et al. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone. Clin Neurol Neurosurg. 2005;107(6):497-508. (Pubitemid 41395226)
5. Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Persons. Using antipsychotic agents in older patients. J Clin Psychiatry. 2004;65(suppl 2):5-104.
6. Zuidema SU, van Iersel MB, Koopmans RT, et al. Efficacy and adverse reactions of antipsychotics for neuropsychiatric symptoms in dementia: a systematic review [in Dutch]. Ned Tijdschr Geneeskd. 2006;150(28):1565-1573. (Pubitemid 44097854)
7. Rosack J. FDA orders new warning on atypical antipsychotics. Psychiatric News. 2005;40(9):1.
8. Trzepacz PT. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry. 2000;5(2):132-148.
9. American Psychiatric Association. Practice guideline for the treatment of patients with delirium. Am J Psychiatry. 1999;156(5 suppl):1-20.
10. Sawin G, Shaughnessy AF. Glucose control in hospitalized patients. Am Fam Physician. 2010;81(9):1121-1124.
11. Zaudig M. A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms of dementia. Drug Saf. 2000;23(3):183-195.
12. Ozbolt LB, Paniagua MA, Keiser RM. Atypical antipsychotics for the treatment of delirious elders. J Am Med Dir Assoc. 2008;9(1):18-28.